Literature DB >> 19131814

Variation in the TLR4 gene influences the risk of organ failure and shock posttrauma: a cohort study.

Sherene Shalhub1, Christopher E Junker, Scott D Imahara, Michael N Mindrinos, Sharmila Dissanaike, Grant E O'Keefe.   

Abstract

BACKGROUND: Genetic variation contributes to risk and outcomes of sepsis. We sought to determine whether variation in inflammation related genes is associated with severity of sepsis in trauma patients.
METHODS: A cohort of severely injured Caucasian patients was studied and genotyped for candidate single nucleotide polymorphisms (SNPs). These were toll-like receptor 4 (TLR4) A896G, tumor necrosis factor-alpha G-308A, interleukin-6 G-174C, interleukin-1beta C-31T, and cluster of differentiation marker 14C-159T. SNP genotypes among patients with sepsis and complicated sepsis were analyzed by chi2 and logistic regression. Six haplotype-tagging SNPs in the TLR4 gene were subsequently examined to analyze their influence on TLR4 A896G SNPs relationship to sepsis severity.
RESULTS: We enrolled 598 patients. Complicated sepsis developed in 147 (25%). Adjusting for independent risk factors, carriage of the variant TLR4 896 G allele was associated with decreased risk of complicated sepsis (odds ratio = 0.3, 95% confidence interval, 0.1-0.7, p = 0.008). Furthermore, two haplotypes seemed to better characterize this risk than the variant TLR4 896G allele. The variant TLR4 896G allele is linked to one common haplotype, which seems to confer a considerably reduced risk of complicated sepsis. (aOR = 0.2 95% confidence interval, 0.05-0.7, p = 0.01).
CONCLUSIONS: Variation within TLR4 gene is associated with severity of posttraumatic sepsis. This risk may not be solely related to TLR4 A896G SNP. It is likely that other, uncharacterized variations in the TLR4 gene contribute to sepsis severity. A thorough evaluation of variability within the TLR4 gene is needed to characterize sepsis risk.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19131814      PMCID: PMC2740632          DOI: 10.1097/TA.0b013e3181938d50

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  30 in total

1.  The structure of haplotype blocks in the human genome.

Authors:  Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler
Journal:  Science       Date:  2002-05-23       Impact factor: 47.728

2.  TLR4 mutations are associated with endotoxin hyporesponsiveness in humans.

Authors:  N C Arbour; E Lorenz; B C Schutte; J Zabner; J N Kline; M Jones; K Frees; J L Watt; D A Schwartz
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

3.  Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections.

Authors:  Doreen M Agnese; Jacqueline E Calvano; Sae J Hahm; Susette M Coyle; Siobhan A Corbett; Steve E Calvano; Stephen F Lowry
Journal:  J Infect Dis       Date:  2002-10-29       Impact factor: 5.226

4.  The G-->A single nucleotide polymorphism at the -308 position in the tumor necrosis factor-alpha promoter increases the risk for severe sepsis after trauma.

Authors:  Grant E O'Keefe; Dixie L Hybki; Robert S Munford
Journal:  J Trauma       Date:  2002-05

5.  Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock.

Authors:  Eva Lorenz; Jean Paul Mira; Kathy L Frees; David A Schwartz
Journal:  Arch Intern Med       Date:  2002-05-13

6.  A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease.

Authors:  R C Read; J Pullin; S Gregory; R Borrow; E B Kaczmarski; F S di Giovine; S K Dower; C Cannings; A G Wilson
Journal:  J Infect Dis       Date:  2001-07-30       Impact factor: 5.226

7.  Excess of rare amino acid polymorphisms in the Toll-like receptor 4 in humans.

Authors:  I Smirnova; M T Hamblin; C McBride; B Beutler; A Di Rienzo
Journal:  Genetics       Date:  2001-08       Impact factor: 4.562

8.  Interleukin-1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis.

Authors:  F Arnalich; D López-Maderuelo; R Codoceo; J Lopez; L M Solis-Garrido; C Capiscol; C Fernandez-Capitán; R Madero; C Montiel
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

9.  Sepsis syndrome and death in trauma patients are associated with variation in the gene encoding tumor necrosis factor.

Authors:  Thilo Menges; Inke R König; Hamid Hossain; Simon Little; Svetlin Tchatalbachev; Felix Thierer; Holger Hackstein; Isolda Franjkovic; Thorsten Colaris; Florian Martens; Katja Weismüller; Tanja Langefeld; Jürgen Stricker; Gunter Hempelmann; Pieter E Vos; Andreas Ziegler; Bram Jacobs; Trinad Chakraborty; Gregor Bein
Journal:  Crit Care Med       Date:  2008-05       Impact factor: 7.598

Review 10.  A comprehensive review of genetic association studies.

Authors:  Joel N Hirschhorn; Kirk Lohmueller; Edward Byrne; Kurt Hirschhorn
Journal:  Genet Med       Date:  2002 Mar-Apr       Impact factor: 8.822

View more
  27 in total

1.  Burn serum causes a CD14-dependent mitochondrial damage in primary cardiomyocytes.

Authors:  Qun S Zang; David L Maass; Jane G Wigginton; Robert C Barber; Bobbie Martinez; Ahamed H Idris; Jureta W Horton; Fiemu E Nwariaku
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-03-26       Impact factor: 4.733

2.  Tumor necrosis factor -308 polymorphism (rs1800629) is associated with mortality and ventilator duration in 1057 Caucasian patients.

Authors:  Eizo Watanabe; Barbara A Zehnbauer; Shigeto Oda; Yasunori Sato; Hiroyuki Hirasawa; Timothy G Buchman
Journal:  Cytokine       Date:  2012-06-28       Impact factor: 3.861

3.  Melanocortin-1 Receptor Polymorphisms and the Risk of Complicated Sepsis After Trauma: A Candidate Gene Association Study.

Authors:  Max E Seaton; Brodie A Parent; Ravi F Sood; Mark M Wurfel; Lara A Muffley; Grant E O'Keefe; Nicole S Gibran
Journal:  Shock       Date:  2017-01       Impact factor: 3.454

4.  A genome-wide in vitro bacterial-infection screen reveals human variation in the host response associated with inflammatory disease.

Authors:  Dennis C Ko; Kajal P Shukla; Christine Fong; Michael Wasnick; Mitchell J Brittnacher; Mark M Wurfel; Tarah D Holden; Grant E O'Keefe; Brian Van Yserloo; Joshua M Akey; Samuel I Miller
Journal:  Am J Hum Genet       Date:  2009-08-06       Impact factor: 11.025

5.  IL1RN coding variant is associated with lower risk of acute respiratory distress syndrome and increased plasma IL-1 receptor antagonist.

Authors:  Nuala J Meyer; Rui Feng; Mingyao Li; Yang Zhao; Chau-Chyun Sheu; Paula Tejera; Robert Gallop; Scarlett Bellamy; Melanie Rushefski; Paul N Lanken; Richard Aplenc; Grant E O'Keefe; Mark M Wurfel; David C Christiani; Jason D Christie
Journal:  Am J Respir Crit Care Med       Date:  2013-05-01       Impact factor: 21.405

6.  Toll-like receptor 1 polymorphisms and associated outcomes in sepsis after traumatic injury: a candidate gene association study.

Authors:  Callie M Thompson; Tarah D Holden; Gail Rona; Balaji Laxmanan; R Anthony Black; Grant E OʼKeefe; Mark M Wurfel
Journal:  Ann Surg       Date:  2014-01       Impact factor: 12.969

Review 7.  Toll-like receptor polymorphisms, inflammatory and infectious diseases, allergies, and cancer.

Authors:  Andrei E Medvedev
Journal:  J Interferon Cytokine Res       Date:  2013-05-15       Impact factor: 2.607

8.  Distinct and replicable genetic risk factors for acute respiratory distress syndrome of pulmonary or extrapulmonary origin.

Authors:  Paula Tejera; Nuala J Meyer; Feng Chen; Rui Feng; Yang Zhao; D Shane O'Mahony; Lin Li; Chau-Chyun Sheu; Rihong Zhai; Zhaoxi Wang; Li Su; Ed Bajwa; Amy M Ahasic; Peter F Clardy; Michelle N Gong; Angela J Frank; Paul N Lanken; B Taylor Thompson; Jason D Christie; Mark M Wurfel; Grant E O'Keefe; David C Christiani
Journal:  J Med Genet       Date:  2012-10-09       Impact factor: 6.318

9.  A Potential Mechanism for Immune Suppression by Beta-Adrenergic Receptor Stimulation following Traumatic Injury.

Authors:  Nicholas J Shubin; Tam N Pham; Kristan Lea Staudenmayer; Brodie A Parent; Qian Qiu; Grant E O'Keefe
Journal:  J Innate Immun       Date:  2018-02-16       Impact factor: 7.349

10.  A MIF haplotype is associated with the outcome of patients with severe sepsis: a case control study.

Authors:  Lutz E Lehmann; Malte Book; Wolfgang Hartmann; Stefan U Weber; Jens-Christian Schewe; Sven Klaschik; Andreas Hoeft; Frank Stüber
Journal:  J Transl Med       Date:  2009-11-26       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.